4
Changes in Ownership
ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001181431-14-006597
CFO sold 16,000 shares at $18.77 ($300,290)
- CFO acquired 16,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Myszkowski Kenneth Allen · CFO
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2014-02-12 | Exercise or conversion : show line 1 in the form | +16,000 | $2.01 | $32,160 | 87,500 | D |
| 2014-02-12 | Sale : show line 2 in the form | −16,000 | $18.77 | $300,290 | 71,500 | D |
| Open-market sales · 16,000 sh · avg $18.77 · $300,290 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2014-02-12 | Exercise or conversion : show line 3 in the form Stock Option | −16,000 | 312,000 | D |
Loading xslF345X03/rrd402396.xml…